Topic: Health
Scientists have discovered why losing fat in certain conditions can lead to diabetes. They found that abnormal fat loss and uneven fat distribution can cause major changes in gene activity, leading to inflammation and damage to cells. This research could help improve treatment options for people with rare genetic and autoimmune conditions.
Fat tissue is often seen as something the body would be better off without. However, scientists now know that adipose tissue is an active and essential organ that supports many important processes, including energy storage, hormone production, and metabolic regulation.
Too much fat can increase the risk of diabetes, heart disease, and other health problems. But the opposite can also be dangerous. In rare genetic and autoimmune conditions such as familial partial lipodystrophy type 2 (FPLD2), abnormal fat loss and uneven fat distribution can lead to diabetes and other metabolic diseases.
A team of researchers led by Dr. Elif Oral, a clinician and Professor in the Division of Metabolism, Endocrinology and Diabetes, has been trying to understand this apparent contradiction. They worked with patients who have FPLD2, along with Ormond MacDougald, Ph.D., and graduate student researcher Jessica Maung, Ph.D.
The researchers developed a mouse model where they could switch off the lamin A/C gene specifically in adipocytes. This is the same gene that is mutated in people with FPLD2. They found major changes in gene activity that prevented fat cells from properly processing and storing lipids.
At the same time, the adipocytes and the immune cells within the fat tissue shifted into a pro-inflammatory state. The mitochondria inside the fat cells also stopped functioning normally. Mitochondria help generate energy for cells, so their failure can have widespread effects on cell health.
The researchers hope that their findings will point to new therapeutic targets. One possibility is to protect adipose tissue before it deteriorates, preventing fat cells from disappearing and reducing the metabolic damage caused by the disease.
Why It Matters
This research has significant implications for people with rare genetic and autoimmune conditions in India. It could lead to improved treatment options and better management of diabetes and other metabolic diseases.
Key Facts
- Familial partial lipodystrophy type 2 (FPLD2) is a rare genetic condition that causes abnormal fat loss and uneven fat distribution, leading to diabetes and other metabolic diseases.
- The researchers developed a mouse model where they could switch off the lamin A/C gene specifically in adipocytes, which is mutated in people with FPLD2.
- Major changes in gene activity were found in patients with FPLD2, preventing fat cells from properly processing and storing lipids.
- The mitochondria inside fat cells stopped functioning normally, leading to inflammation and damage to cells.
- This research could lead to improved treatment options for people with rare genetic and autoimmune conditions.
Key Terms
- Adipose tissue
- Fat tissue that supports energy storage, hormone production, and metabolic regulation
- Mitochondria
- The parts of cells where energy is generated
- Lamin A/C gene
- A gene that provides instructions for making proteins that help regulate cell growth and division
Implications
This research has significant implications for people with rare genetic and autoimmune conditions in India. It could lead to improved treatment options and better management of diabetes and other metabolic diseases.
Leave a comment